Cardiolyse
PrivateLast Round
Grant
Aug 26, 2022
Total Funding Raised
$100,000
Company Overview
Cardiolyse operates in Healthcare & Life Sciences and is based in Helsinki. Its latest recorded funding round was a Grant round in August 2022.
Cardiolyse is a healthtech company that provides a cloud-based ECG and HRV analytics platform for real-time remote heart health monitoring and predictive cardiac diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Medical AI, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cardiolyse Comparables
Compare Cardiolyse with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Idoven | 84% | |
| PulseAI | 83% | |
| AccurKardia | 83% |
For institutional investors. Book with your work email.
Cardiolyse Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 26, 2022 | ||||
| Crowdfunding | Oct 14, 2021 | ||||
| Accelerator | Jul 23, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cardiolyse Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startupbootcamp | Accelerator |
| Aescuvest | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2021
Aescuvest participated in the round.
- Jul 23, 2018
Startupbootcamp led the accelerator round.
For institutional investors. Book with your work email.
Cardiolyse Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cardiolyse's valuation, stock price, and market status.
Is Cardiolyse a public or private company?
Cardiolyse is a private company.
What is the current stock price of Cardiolyse?
Cardiolyse is a private company, so its shares have no public market price. Caplight tracks Cardiolyse's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cardiolyse worth (valuation)?
Valuation information for Cardiolyse is not publicly available.
Can I buy Cardiolyse stock?
Cardiolyse shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cardiolyse's last funding round?
Cardiolyse's most recent funding round was Grant on August 26, 2022.
Who are the main investors in Cardiolyse?
Key investors in Cardiolyse include Startupbootcamp.
Will Cardiolyse IPO soon?
No public IPO plans have been announced for Cardiolyse.
How can I track Cardiolyse secondary market activity?
Caplight tracks bids, offers, and trades in Cardiolyse's shares on secondary markets.